Ledger.Open graph →
SEC Form D · Amendment · filed July 11, 2014

GeneCentric Diagnostics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Michael A. Costa · San Francisco, CADirectorWilliam Eimicke · Santa Monica, CADirectorDavid Sams · Santa Monica, CAExec · DirectorFarrell M. Ender · Philadelphia, PADirectorDean B. Drysdale · Langley, British Columbia, CanadaExec · DirectorMukesh K. Parekh · SANTA MONICA, CADirectorMark J. Minichello · BOSTON, MAExec · DirectorVlad B. Portnoy · New York, NYExec · DirectorMark W. Martin · Porter, TXDirectorChristopher Cutter · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗